UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009639
Receipt No. R000011264
Scientific Title Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17)
Date of disclosure of the study information 2012/12/28
Last modified on 2019/09/05 14:50:23

No. Disposal Last modified on Item of update
1 Insert 2012/12/26 20:33:44
2 Update 2013/01/02 22:47:57 Condition
Key secondary outcomes
3 Update 2013/06/14 16:28:41 Recruitment status
4 Update 2013/06/27 14:59:29 Institutions
5 Update 2014/01/28 13:48:20 Division name
Email
Institutions
6 Update 2014/07/29 09:39:01 Address
Address
TEL
Address
Address
TEL
7 Update 2014/07/29 09:41:14 Last follow-up date
8 Update 2014/12/26 09:31:01 Recruitment status
Last follow-up date
9 Update 2014/12/26 09:37:50 Institutions
10 Update 2016/06/28 10:42:05 Name of primary sponsor
Organization
11 Update 2018/08/24 10:07:30 UMIN ID1
UMIN ID2
12 Update 2019/09/05 14:46:48 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Address
TEL

Last name of contact person

Last name of contact person
Zip code
Address
Address
Organization
Organization
Address
Address
Tel
Email
13 Update 2019/09/05 14:48:36 Number of participants that the trial has enrolled
Results Delayed
Results Delay Reason
Results Delay Reason
14 Update 2019/09/05 14:49:52 Number of participants that the trial has enrolled
15 Update 2019/09/05 14:50:23 Date of IRB


Contact us.